Bruce, Matthew P.
Commonwealth Scientific and Industrial Research Organisation · Australian Centre for Disease Preparedness
3 papers on CoChat
Most cited papers
- Verified
At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant
Singanallur, N. B., van Vuren, P. J., McAuley, A. J., Bruce, M. P., Kuiper, M. J., Gwini, S. M., Riddell, S., Goldie, S., Drew, T. W., Blasdell, K. R., et al. (2022) · Frontiers in Immunology
SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy
Cited by 15
- Verified
At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant
Singanallur, N. B., van Vuren, P. J., McAuley, A. J., Bruce, M. P., Kuiper, M. J., Gwini, S. M., Riddell, S., Goldie, S., Drew, T. W., Blasdell, K. R., et al. (2022) · Frontiers in Immunology
SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy
Cited by 15
- Verified
Highly Thermotolerant SARS-CoV-2 Vaccine Elicits Neutralising Antibodies Against Delta and Omicron in Mice
van Vuren, P. J., McAuley, A. J., Kuiper, M. J., Singanallur, N. B., Bruce, M. P., Riddell, S., Goldie, S., Mangalaganesh, S., Chahal, S., Drew, T. W., et al. (2022) · Viruses
SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches
Cited by 9
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free